Medtronic tops Q3 estimates, backs $700M push into heart tech and robotics
What's the deal? MedtronicDealroom has a profile for this one. Try Dealroom → reported Q3 earnings of $1.45 per share on revenue of $9.76 billion, beating consensus estimates of $1.39 and $9.55 billion. It raised its full-year outlook, citing broad demand for its cardiovascular devices.
What's the endgame? The company is investing more than $700 million in platforms like Heart Tech and Robotics, including a new robot surgeon. The bet aims to drive future growth beyond its current device lineup.
Why now? The beat and raised guidance point to momentum across Medtronic's core business, giving it room to fund longer-term technology plays.
The signal: Medtronic is pairing steady device demand with a push into surgical robotics, a signal that the medtech giant sees automation as its next growth engine.
Read more: pluang.com
Image credit: gabofr
